v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock  
Common Stock  
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
(Accumulated Deficit) Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2020 [1]       1,225,288,710 1,225,288,710                
Balance, beginning of the year at Dec. 31, 2020 $ 6,400,723 $ (150,612) $ 6,250,111 $ 6,115,232 $ 6,115,232 $ 261,436 $ (158,810) $ 102,626 $ 8,770 $ 8,770 $ 15,285 $ 8,198 $ 23,483
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Exercise of stock options (in shares) 14,948,400     14,948,400 [1]                  
Exercise of stock options $ 108,594     $ 166,057   (57,463)              
Stock-based compensation 330,763         330,763              
Vesting of restricted share units (in shares) [1]       6,934,480                  
Vesting of restricted share units 0     $ 214,852   (214,852)              
Issuance of shares (in shares) [1]       11,800,000                  
Issuance of Class A subordinate voting shares, net of offering costs 1,543,958     $ 1,543,958                  
Net income and comprehensive income (loss) for the year 2,899,915               (14,744)   2,914,659    
Common shares outstanding, ending balance (in shares) at Dec. 31, 2021 [1]       1,258,971,590                  
Balance, end of the year at Dec. 31, 2021 $ 11,133,341     $ 8,040,099   161,074     (5,974)   2,938,142    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Exercise of stock options (in shares) 3,126,869     3,126,869 [1]                  
Exercise of stock options $ 17,549     $ 34,815   (17,266)              
Stock-based compensation 549,142         549,142              
Vesting of restricted share units (in shares) [1]       7,380,507                  
Vesting of restricted share units 0     $ 470,524   (470,524)              
Issuance of shares (in shares) [1]       1                  
Issuance of shares related to business acquisitions (in shares) [1]       5,649,600                  
Issuance of shares related to business acquisitions 9,774     $ 201,994   (192,220)              
Net income and comprehensive income (loss) for the year (3,470,917)               (10,499)   (3,460,418)    
Common shares outstanding, ending balance (in shares) at Dec. 31, 2022 [1]       1,275,128,567                  
Balance, end of the year at Dec. 31, 2022 $ 8,238,889     $ 8,747,432   $ 30,206     $ (16,473)   $ (522,276)    
[1] Prior year share amounts have been retrospectively adjusted to reflect the Share Split effected in June 2022. See Note 19 for details.